Spotlight on Grazoprevir—elbasvir Once-Daily Combination and Its Potential in the Treatment of Hepatitis C

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s90537
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited